ATE550660T1 - Diagnose einer erkrankung und einstufung von krebs mittels membranelektrophorese - Google Patents

Diagnose einer erkrankung und einstufung von krebs mittels membranelektrophorese

Info

Publication number
ATE550660T1
ATE550660T1 AT08724520T AT08724520T ATE550660T1 AT E550660 T1 ATE550660 T1 AT E550660T1 AT 08724520 T AT08724520 T AT 08724520T AT 08724520 T AT08724520 T AT 08724520T AT E550660 T1 ATE550660 T1 AT E550660T1
Authority
AT
Austria
Prior art keywords
diagnosis
disease
cancer
classification
membrane electrophoresis
Prior art date
Application number
AT08724520T
Other languages
English (en)
Inventor
Frank Chang
Phu Duong
George Tuszynski
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE550660T1 publication Critical patent/ATE550660T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2807—Headache; Migraine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
AT08724520T 2007-07-26 2008-01-15 Diagnose einer erkrankung und einstufung von krebs mittels membranelektrophorese ATE550660T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96208107P 2007-07-26 2007-07-26
PCT/US2008/000509 WO2009014552A1 (en) 2007-07-26 2008-01-15 Method for detecting disease markers

Publications (1)

Publication Number Publication Date
ATE550660T1 true ATE550660T1 (de) 2012-04-15

Family

ID=40281626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08724520T ATE550660T1 (de) 2007-07-26 2008-01-15 Diagnose einer erkrankung und einstufung von krebs mittels membranelektrophorese

Country Status (5)

Country Link
US (1) US8333880B2 (de)
EP (1) EP2176432B1 (de)
AT (1) ATE550660T1 (de)
CA (1) CA2694349C (de)
WO (1) WO2009014552A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010273543B2 (en) * 2009-07-14 2017-06-15 Temple University Of The Commonwealth System Of Higher Education Serum markers associated with early and other stages of breast cancer
US8980269B2 (en) 2009-07-14 2015-03-17 Temple University Of The Commonwealth System Of Higher Education G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker
US8420333B2 (en) 2009-07-14 2013-04-16 Temple University Of The Commonwealth System Of Higher Education G-protein coupled receptor-associated sorting protein 1 as a cancer biomarker
US20130125910A1 (en) * 2011-11-18 2013-05-23 Avon Products, Inc. Use of Electrophoretic Microcapsules in a Cosmetic Composition
WO2013076943A1 (ja) * 2011-11-22 2013-05-30 パナソニック株式会社 生体分子の１分子検出方法および１分子検出装置、疾病マーカ検査装置
CN103743802A (zh) * 2014-01-10 2014-04-23 南京师范大学 基于三维有序金掺杂纳米二氧化钛电极的dna生物传感器及其制备和应用
WO2016011143A1 (en) 2014-07-15 2016-01-21 Temple University Of The Commonwealth System Of Higher Education Stabilized peptide fragments from redoxin proteins as cancer biomarkers
CN107207024B (zh) 2014-10-03 2020-08-18 银威欧马达私人有限公司 改进型单轨列车系统、方法以及组件

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984298A (en) 1970-12-28 1976-10-05 Haber Instruments, Incorporated Electromolecular propulsion in semiconductive media
US3930973A (en) 1972-03-10 1976-01-06 Nerenberg Samuel T Electrophoretic process
US4128470A (en) 1975-08-29 1978-12-05 Fuji Photo Film Co., Ltd. Supports for electrophoresis and process for the production of the same
JPS63262550A (ja) 1987-04-20 1988-10-28 Fuji Photo Film Co Ltd 電気泳動用支持体
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias
US4857163A (en) 1987-07-17 1989-08-15 Beckman Instruments, Inc. High resolution electrophoretic gel and method for separating serum proteins
US4909918A (en) 1988-09-06 1990-03-20 Bambeck Gregory S Disposable comb for electrophoresis device
US5068019A (en) 1989-05-19 1991-11-26 Fuji Photo Film Co., Ltd. Electrophoresis film support
BE1005220A3 (fr) 1991-01-15 1993-06-01 Analis Sa Procede de separation, d'identification et de quantification d'isoenzymes et d'isoformes de la phosphatase alcaline.
US5137609A (en) 1992-01-31 1992-08-11 Biometric Imaging Inc. Differential separation assay
US5314595A (en) 1992-04-03 1994-05-24 United States Biochemical Corporation Electrophoresis of nucleic acid fragments
US5637202A (en) 1993-10-27 1997-06-10 California Institute Of Technology Porous electrophoresis sponges
US6528640B1 (en) * 1997-11-05 2003-03-04 Ribozyme Pharmaceuticals, Incorporated Synthetic ribonucleic acids with RNAse activity
US6855554B2 (en) * 2001-09-21 2005-02-15 Board Of Regents, The University Of Texas Systems Methods and compositions for detection of breast cancer
US20030211624A1 (en) 2001-11-20 2003-11-13 Board Of Regents, The University Of Texas System Proteomic methods for diagnosis and monitoring of breast cancer
WO2004025253A2 (en) 2002-09-11 2004-03-25 Temple University - Of The Commonwealth System Of Higher Education Method of visualizing proteins bound to protein-binding membranes
WO2004025250A2 (en) * 2002-09-11 2004-03-25 Temple University - Of The Commonwealth System Of Higher Education System and methods for electrophoretic separation of proteins on protein binding membranes
US20060068452A1 (en) 2004-09-29 2006-03-30 Power3 Medical Products, Inc. Differential protein expression patterns related to disease states
US20070161030A1 (en) * 2005-12-08 2007-07-12 Perkinelmer Las, Inc. Micelle-and microemulsion-assisted planar separations platform for proteomics

Also Published As

Publication number Publication date
US20110031122A1 (en) 2011-02-10
EP2176432B1 (de) 2012-03-21
WO2009014552A1 (en) 2009-01-29
EP2176432A1 (de) 2010-04-21
CA2694349C (en) 2013-07-09
US8333880B2 (en) 2012-12-18
EP2176432A4 (de) 2010-11-03
CA2694349A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
Clark et al. Evaluation of MALDI-TOF mass spectroscopy methods for determination of Escherichia coli pathotypes
EP2176432A4 (de) Verfahren zum nachweis von krankheitsmarkern
GB2568608A (en) Personalized genetic testing
WO2011008746A3 (en) Serum markers associated with early and other stages of breast cancer
HK1223659A1 (zh) 基於可多重标签的报告系统
EP4411362A3 (de) Vorrichtung, systeme und verfahren für kapillarelektrophorese
CN110249223A (zh) 血液细胞分析方法及血液细胞分析仪
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
BR112015023394B8 (pt) Sistema e complexo bioluminescente
WO2008093098A3 (en) Methods for indexing samples and sequencing multiple nucleotide templates
EP2145180A4 (de) Vergleichende sequenzanalyseverfahren und -systeme
NZ587750A (en) Molecular diagnosis and classification of malignant melanoma
WO2010025341A3 (en) Determining age ranges of skin samples
WO2012177940A3 (en) Microfluidic devices and methods for separating and detecting constituents in a fluid sample
EP2363505A3 (de) Melanomdiagnose mittels nukleinsäureanalyse
SG10201807867XA (en) Simultaneous detection of target protein and target nucleic acids in a single cell
ATE554389T1 (de) Apex als marker für lungenkrebs
MX2021007292A (es) Composiciones de conjugados de estreptavidina-oligo de ocupación de pmhc.
WO2019060914A3 (en) Methods and systems for performing single cell analysis of molecules and molecular complexes
WO2005098445A3 (en) Lung cancer biomarkers
ATE514090T1 (de) Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen
WO2013166444A3 (en) Biomarker analysis using scodaphoresis
WO2019139980A8 (en) Methods for measuring analyte and/or protein in biological samples
ATE405841T1 (de) In-vitro-verfahren zum gleichzeitigen nachweisen und identifizieren von antibiotika unterschiedlicher klassen sowie entsprechender diagnostischer kit
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids